Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28062192 | 0.98 | ALDH1A1 (0.35) | ALDH1A1LMNAOPRD1CA1CA2 | |
| SCHEMBL24493269 | 0.76 | EGFR (0.30) | CA1CA2 | |
| SCHEMBL30950742 | 0.74 | RAB9A (0.37) | ALDH1A1 | |
| SCHEMBL28122675 | 0.73 | — | — | |
| SCHEMBL29561757 | 0.72 | ALDH1A1 (0.38) | ALDH1A1 | |
| SCHEMBL19633072 | 0.71 | — | — | |
| SCHEMBL28178883 | 0.71 | ALDH1A1 (0.33) | ALDH1A1OPRD1 | |
| SCHEMBL28219230 | 0.71 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL27761248 | 0.70 | ALDH1A1 (0.36) | ALDH1A1 | |
| SCHEMBL275807 | 0.70 | CA1 (0.33) | CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107205972-A | Substituted N- (2- (amino) -2-oxoethyl) benzamide inhibitors of autotaxin and their preparation and use in the treatment of LPA-dependent or LPA-mediated diseases | X-RX股份有限公司 | 2017-09-26 | — | — | CN | claimed |
| CN-107205972-A | Substituted N- (2- (amino) -2-oxoethyl) benzamide inhibitors of autotaxin and their preparation and use in the treatment of LPA-dependent or LPA-mediated diseases | X-RX股份有限公司 | 2017-09-26 | — | — | CN | disclosed |